chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029A21A and 029A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea) and FATIGUE (Fatigue). At the time of the report, DIARRHOEA (Diarrhea) and FATIGUE (Fatigue) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No concomitant medicines were reported. No treatment information were reported.
Pediatric dose 10mcg/0.5 ml Hepatitis B vaccine (Engerix-B) administered on 4/30/07 and 6/1/07 instead of an adult dose No adverse events noted.
Pt felt dizzy after receiving her shot. She also was pale and her blood pressure was low (diastolic in the 50's 5 minutes post-imz and 105/73 10 minutes post-imz). Pt was given a cold pack to place on her neck and she sat until she felt well enough to leave.
A report was received from a health care professional on 11/04/03 concerning a 24 month old male vaccinee who inadvertently received Fluvirin on 10/29/03. The vaccinee had not experienced any adverse reaction at the time of the report. There was insufficient information to determine the reporter's causality assessment. Update 1, 11/25/03: A follow up report was received from a health care professional which indicated that the vaccinee was 31 months old when he received Fluvirin on 10/28/03. The vaccinee had still not experienced any adverse reaction at the time of the report. No follow up pending. See Ref.: PJP200300983 and PJP200300984.
Wednesday night-9 days post vaccine began with intense headache. Slept straight through for 12 hours. Woke up with intense headache, body aches, neck pain. At 5pm on Thursday, began vomiting. Alternated between vomiting and sleeping for 24 hours until I received an order for zofran. Vomiting stopped. Sleeping and massive headache continued until Saturday. Saturday I went for a covid test. Negative rapid.  Sunday- totally fine
Adult vial was provided and unknowingly administered undiluted.  Diluent was thought to have been added to Pfizer stock vial. Total of 0.2cc administered. Patient had sore injection site that day. Had temperature over night and belly pain. Next day had vomiting that resolved with zofran. And patient played in the snow twice in the afternoon without complaints.
Case number PHHY2015US172889, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS reference number: 607110): on 29 Dec 2015. This report refers to a 07 years old female patient. Historical condition included deaf left ear, current condition included: stomach ache. Concomitant medication was not reported, The patient was vaccinated with seasonal influenza vaccine (manufacture unknown, batch number not reported) into left arm on 29 Oct 2015. On 30 Oct 2015, the patient was broke out in hives at school. The patient was sent to home. They called the physician and was told to give her BENADRYL. The outcome of the event was complete recovery on an unknown date. The seriousness of the event reported as non serious and causality was not reported.
Two twins were in for their 4 month old check up as a new patient in our office on 6/23/21. They were due for vaccinations: Rotavirus, DTap-HIB-IPV, and PCV-13. We administered Rotavirus and PCV-13 with correct vaccinations, however we inadvertently administered Kinrix (DTap-IPV) instead of Pediarix (DTap-HepB-IPV) or Pentacel (DTap-HIB-IPV). Kinrix is approved for children 4-6 years of age whereas Pediarix is approved for children 6 weeks of age - 6 years of age, and Pentacel is approved for 6 weeks - 4 years of age.  Kinrix: GlaxoSmithKline vaccine, 0.5 mL intramuscular injection of DTap/IPV  This mistake of administering Kinrix was made due to lack of information on vaccine packaging (it did not provide age ranges on the box or in the package insert) and my human error. After reviewing CDC and vaccination guidelines/information on this event, it was found that this would not be harmful to the babies, the brand was just not tested/approved for children at 4 months old. It was the same dosage as the other, approved vaccines for their age with the same content being administered for DTap and IPV to immunize the twins.  The information for the vaccines administered were entered in the patient's chart, Kinrix was documented as out of age range, transmitted to the registry, and I have reached out to registry to ensure that this would be approved on his immunization record toward his immunization status (it is dependent on the individual's state guidelines). The parents were notified of this event on 6/23, and I explained to them everything that happened and ensured them of the safety of their children. I apologized for this human error and made sure they were on the same page with all their questions and concerns.  They were monitored closely and did not have any adverse reactions to this vaccine and it was confirmed by our state guidelines and immunization nurse through registry that this will count toward the twins' immunization status.  We took measures to prevent this from happening in the future by labelling the boxes to make it very clear that Kinrix is for 4-6 year olds and Pediarix is 6 weeks-6 years and Pentacel is 6 weeks-4 years. We also created a schedule for immunization based on the vaccines we have in our office clearly marking for each age range and vaccine type required. All staff members were informed of this situation to learn from this mistake.
23 year old male who was previously healthy, was being prepared for deployment and received multiple vaccinations including hepatitis B shot. Patient's parent was contacted because he had an allergic reaction to his hepatitis B shot. Patient was transferred to hospital where he had N/V and jaundice after being transferred earlier on 8/6/04. Patient was found to have a total bilirubin of 15 and elevated LFTs, acute hepatitis B infection which progressed to fulminant hepatic failure and then transferred to another hospital for further evaluation for possible emergent liver transplantation. Follow up 02/09/05: Patient's recovery status is still unknown. Patient had emergent liver transplantation. He was previously healthy prior to receiving multiple vaccinations including hepatitis B shot. To really anser your question about recovery, I can not definitely answer yes or no. All I can say is that the patient sucessfully had emergent liver transplantation.
Approximately one day after the moderna injection, in addition to typical side effects of difficulty lifting up for 72 hours, fevers, chills, body aches, sweats, I also had electrical sensations down my arms, legs, vibrating sensation in my brain, squeezing of my groin, abdomen, chest, legs and arms, along with pins and needles, sharp prickly sensations in my toes, fingers and numbness of the left side of my face, lips and chin. I also had a rash on both my elbow and knees as well as fingers and hands. These symptoms gradually improved after several months once I started taking an immunosuppressant medication. It affected my mood and I subsequently developed PTSD/depression and anxiety and had to take medications for it. It was almost better and so I decided to get the second moderna shot 4 and a half months later on May 20, 2021 so I could be considered fully vaccinated as a health care worker (physician) and protect my patients, family and staff members. The symptoms all returned and I had to get to taking an immunosuppressant again. Now, 6 months later after my second shot, I still have these adverse side effects when I try to go off the immunosuppressant.  It is exactly ten months later from my first shot and I have never been the same again. I cannot take the booster although it is advised for me to take it as a health care worker.
Initial information received from nurse on 04-Oct-2013. Patient got FLUZONE HD broke out in a rash on the side of her arm. Red, raised, warm to touch, tingly and burning sensation. Getting bigger. Located distal to the injection site. Injection site is does not have a rash. No other symptoms.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant medications were not reported. On 20-JUL-2016, the patient was vaccinated with the improperly stored dose of M-M-R II (lot # L026553, albumin status rHA; dose, route, expiration date were not reported).  This is one of several reports received from the same reporter. Additional information has been requested.
Fever, NauseaVomiting, chills, weakness, pain at injection site Narrative:
Patient received dose 1 of Pfizer vaccine on 1/26/21 and dose 2 on 2/16/21.  Patient admitted to the hospital on 3/13/21 with COVID-19 diagnosis.
Seven days following immunization, felt sensitivity under both arms, in arm pits. Next day developed bumps in armpits. Bumps became blisters, fluid thick white to tan/green. Blisters resolved over next 2 to 3 weeks.
This non serious case was received on 06 April 2009 from a health care professional. A 4 and a half year old female patient received DAPTACEL (lot number C3082AA) in the right arm, IPOL (lot number A1229-2) in the right arm, PROQUAD (manufacturer Merck, lot number 0034Y) in the left arm, and VARIVAX (manufacturer Merck, lot number 0044Y) in the left arm on 02 April 2009. On 03 April 2009 the patient's right arm became swollen and red. On 04 April 2009 the patient's right arm developed blisters. The patient had one large blister at the injection site with smaller blisters around the arm from the shoulder to elbow. The patient stated that the blisters appeared on their own and the area is still reddened. Follow up information received on 21 April 2009 from a health care professional who reported that the patient was taking CLARITIN concomitantly. The patient received MMR II (manufacture Merck), which was previously captured as PROQUAD. The patient recovered from the events. Date of recovery was not reported. Follow-up information was received from the reporter on 08 May 2009. All vaccines were given intramuscularly. MMR II and VARIVAX had each been given once previously. The patient was fully recovered from all events on 15 April 2009. No additional information was available at the time of the report. List of Documents held by Sender: None.
Dry cough 14 days of nightly fevers ranging from 99.5 to 101.5 Night sweats Fatigue Inability to exercise Loss of appetite
p/vax pt devel intermittent spells which included staring blank; stiffening up whole body & hyperextension of neck; in between spills acted as usual but appeared scared
developed Meniere's disease; It's severe and affecting my daily life; pregnant at the time of vaccination; This is a spontaneous report from a contactable consumer (patient). A 23-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6206), via an unspecified route of administration into left arm on 05Mar2021 17:30 as single dose for COVID-19 immunisation. The patient's medical history was not reported. Concomitant medications include prenatal vitamins (unspecified). Patient was reportedly pregnant at the time of vaccination 05Mar2021 17:30 and was due to deliver on 29Jul2021. The last menstrual period was 23Oct2020. On 12Mar2021, patient developed meniere's disease which was reportedly severe and affecting her daily life. The patient was reportedly hospitalized on an unspecified date for 1 day. It was also reported that the patient was given a prescription for physical therapy as treatment. Outcome of events was not recovered.
Received vaccine booster (0.25 mL) at 17:30. After waking up at 08:00 the day after the vaccine, had fatigue, muscle aches, and began having palpitations every 5-10 minutes. As a cardiac nurse, knew to take 800 mg of ibuprofen at 10:00 as a precaution to reports of mild myocarditis associated with the vaccine. Went to take a nap at 11:00, still with all of the symptoms listed above. Woke up at 14:30 with fatigue and muscle aches. So far have only had 1 instance of palpitations.
Headache, muscle aches, chest tightness, unable to focus and palpitations.
Breakthrough case admission after 2 vaccines Moderna 3/3/21 Lot# 030A21A;  Moderna 3/31/21 Lot# 018B21A
Fever of 100.8 day after vaccination; Dose number:3; Extreme fatigue; Headache; Eye ache; Right arm (entire side of body) very sore; Right arm (entire side of body) very sore; Local inflammation at injection site; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 01Dec2021 16:30 (Batch/Lot number: unknown) at the age of 62 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Prediabetes" (unspecified if ongoing). The patient's concomitant medications were not reported. Past drug history included: Monistat, reaction(s): "Drug allergy", notes: Known allergies: Monistat. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE, Lot number: unknown Route of administration: unspecified Administration time: 04:45 Anatomical site: right arm), administration date: 18Jan2021, when the patient was 61 years old, for COVID-19 immunisation; Bnt162b2 (DOSE 2, SINGLE, Lot number: unknown Route of administration: unspecified Administration time:16:00 Anatomical site: left arm), administration date: 03Feb2021, when the patient was 61 years old, for COVID-19 immunisation, reaction(s): "Inappropriate schedule of vaccine administered". The following information was reported: IMMUNISATION (non-serious) with onset 01Dec2021 16:30, outcome "unknown", described as "Dose number:3"; FATIGUE (non-serious) with onset Dec2021, outcome "recovering", described as "Extreme fatigue"; PYREXIA (non-serious) with onset 02Dec2021, outcome "recovering", described as "Fever of 100.8 day after vaccination"; HEADACHE (non-serious) with onset Dec2021, outcome "recovering", described as "Headache"; EYE PAIN (non-serious) with onset Dec2021, outcome "recovering", described as "Eye ache"; PAIN IN EXTREMITY (non-serious), PAIN (non-serious) all with onset Dec2021, outcome "recovering" and all described as "Right arm (entire side of body) very sore"; VACCINATION SITE INFLAMMATION (non-serious) with onset Dec2021, outcome "recovering", described as "Local inflammation at injection site". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of fatigue, pyrexia, headache, eye pain, pain in extremity, pain, vaccination site inflammation.  Additional information: The patient did not receive any other vaccines within four weeks prior to the prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The events onset date was also reported as 30Nov2021 at 20:00   The lot number for bnt162b2 was not provided and will be requested during follow up.
Approx 1 1/2" Localized red, raised, firm, warm area @ injection site-morning after injection and still present @ report time.
Funny sensation in throat, feeling of throat closure, approx 5-20 minutes after injection and lasting for approx 15 minutes before resolving on own without medication or intervention.
pt recv vax 23MAY96 & 30MAY96 pt became ill for 10 days;devel a fever, red gums, bumps around mouth, bubbly tongue & 4 to 6 pox around mouth, neck, ears, hands & body;biggest rxn & discomfort was in the mouth;
sore arm; mild headaches; fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported PAIN IN EXTREMITY (non-serious), outcome unknown; HEADACHE (non-serious), outcome recovered; FATIGUE (non-serious), outcome recovered.  Additional information included Headache and fatigue resolved on an unspecified date within 24 hours.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
It was a slow progression. I developed left foot pain. It was diagnosed as Plantar Fasciitis. I had noticed symptoms and then it got worse. I had a doctor appt in June. Treatment: I have a gel that I apply, voltaren, a leg brace that I wear daily, exercises that I am suppose to do. Also will be starting with a physical therapist next week.
Diarrhea for 4 days straight. Insomnia due having to use the bathroom constantly. Symptoms began 0600 the morning after receiving the shot. Approximately 10 poops per day. Poops are pebble-like in nature. Symptoms worsen with consumption of food.
injection site enlarged; swelling; this real warm sensation in the chest immediately after receiving the shot; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of FEELING HOT (this real warm sensation in the chest immediately after receiving the shot), INJECTION SITE SWELLING (injection site enlarged) and SWELLING (swelling) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METOPROLOL for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jan-2021, the patient experienced FEELING HOT (this real warm sensation in the chest immediately after receiving the shot). On an unknown date, the patient experienced INJECTION SITE SWELLING (injection site enlarged) and SWELLING (swelling). On 29-Jan-2021, FEELING HOT (this real warm sensation in the chest immediately after receiving the shot) outcome was unknown. At the time of the report, INJECTION SITE SWELLING (injection site enlarged) and SWELLING (swelling) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Treatment information was not provided. Upon internal review on 4-Aug-21, the age was corrected to 67 years.
Case number PHEH2014US014952 is an initial spontaneous report received from the physician on 24 Jul 2014. This report refers to a patient of unknown identifiers. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with a dose of MENVEO (batch number: not reported) intramuscularly on 23 Jul 2014 or on 24 Jul 2014. It was reported that Men A lyophilized conjugate was reconstituted with sterile water instead of the Men CYW-135 liquid conjugate. No adverse event was reported after the maladministration.
Patient describes experiencing extensive swelling of the arm from the shoulder down to the elbow, starting almost immediately after the shot.  About a week after the shot the symptoms included loss of sensation.  6 months have passed and patient still has partial loss of sensation in hand of the vaccinated arm, including numbness and tingling.   She also describes hand always feeling cold, and has to go to physical therapy twice a week for treatments on her hand. Patient says she was told this will likely be permanent neuropathy.
Patient fell out of chair and was unresponsive about 10 minutes after vaccination. When able to talk complained of itching all over. EpiPen was administered.  During fall landed directly on face resulting in  laceration to nose and subconjunctival hematoma to left eye. Patient continued to be alert and responsive and itching resolved with EpiPen. He was transported by ambulance to Emergency Department.
ANEMIA; EXCESSIVE HAIR LOSS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known history of drug abuse or illicit drug usage .The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: UNKNOWN) dose was not reported, administered on 26-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On 26-MAR-2021, the subject experienced anemia. On 26-MAR-2021, the subject experienced excessive hair loss. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from anemia, and excessive hair loss. This report was non-serious.
Went into AFib on March 1, 2021 which lasted 10 days. Under cardiologist care, I was prescribed Xarelto and Metoprolol. Also tested positive for COVID-19 on January 19, 2022 and went into AFib after one year of not having any cardiac symptoms and still in AFib after 10 weeks, despite medication of Xarelto, Metoprolol, and Flecainide.
Mother called on 10/16/02. Hep B vaccine was administered 9/26/02. She states that on 9/27, pt became irritable and began complaining of intermittent arm and leg pain, to the point that she needed to be carried by her parents. There was no redness, warmth or swelling noted by parents. On 10/11, the pt developed fever followed by cold symptoms. We agreed that was viral. She still had myalgias as well. I spoke with 10/22/02-she no longer is complaining of muscle pain, is not irritable and getting over her cold. Mom is afraid to give her another dose of vaccine.
This spontaneous report as received from a other health professional refers to a unspecified number of patients of unknown age and gender. The patients' medical history and current conditions were not provided. On an unknown dates in approximately 2015 (reported as since 06-JUN-2015), the patients were vaccinated with a doses of GARDASIL (strength, dose and frequency were not reported) lot # K007828 expiration date 02-MAR-2017, lot # K023432, expiration date 18-JUN-2016 and lot # K011562, expiration date 08-APR-2017 that were exposed to temperatures outside of the recommended range. No adverse experience was reported. This is one of several reports received from the same reporter. Additional information has been requested.